Raymond James analyst John Ransom maintained a Hold rating on McKesson (MCK) today. The company’s shares closed last Tuesday at $160.01.
According to TipRanks.com, Ransom is a 5-star analyst with an average return of 9.1% and a 59.9% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, Tenet Healthcare, and Community Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for McKesson with a $188.80 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $172.18 and a one-year low of $112.60. Currently, McKesson has an average volume of 1.04M.
Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MCK in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
